|
SGCB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.36479999524042E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.01039999700347E-08 |
| Normal-vs-Stage2 |
3.542200E-02 |
| Normal-vs-Stage3 |
3.080800E-03 |
| Normal-vs-Stage4 |
5.183800E-02 |
| Stage1-vs-Stage2 |
4.286200E-01 |
| Stage1-vs-Stage3 |
2.946400E-02 |
| Stage1-vs-Stage4 |
1.694360E-02 |
| Stage2-vs-Stage3 |
6.302000E-01 |
| Stage2-vs-Stage4 |
4.331200E-01 |
| Stage3-vs-Stage4 |
6.320000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.74370000052926E-07 |
| Normal-vs-AfricanAmerican |
1.160350E-02 |
| Normal-vs-Asian |
4.173800E-04 |
| Caucasian-vs-AfricanAmerican |
4.934800E-01 |
| Caucasian-vs-Asian |
7.775800E-01 |
| AfricanAmerican-vs-Asian |
5.841400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.800000E-04 |
| Normal-vs-Female |
3.08759999789743E-08 |
| Male-vs-Female |
2.476000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.24170000340251E-08 |
| Normal-vs-Age(41-60Yrs) |
4.752800E-04 |
| Normal-vs-Age(61-80Yrs) |
6.980900E-03 |
| Normal-vs-Age(81-100Yrs) |
8.806000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.285700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.594020E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.686400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.125200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.924600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.901600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.504100E-03 |
| Classical-VS-Follicular |
6.628800E-01 |
| Classical-VS-Other |
6.071800E-01 |
| Classical-VS-Normal |
4.51329995598826E-09 |
| Tall-VS-Follicular |
1.827960E-01 |
| Tall-VS-Other |
6.705600E-01 |
| Tall-VS-Normal |
4.666500E-02 |
| Follicular-VS-Other |
7.917800E-01 |
| Follicular-VS-Normal |
5.100000E-03 |
| Other-VS-Normal |
3.056200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.82671999999773E-05 |
| Normal-vs-N1 |
1.555780E-02 |
| N0-vs-N1 |
1.727950E-01 |
|
|
